Institutional investors control 1.24% of the outstanding shares in ROSG. This represents a greater percentage of ownership than at almost any other company in the Biotechnology industry. Additionally, during the quarter ended June 2013, these large investors purchased a net $17.4 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
NINE CHAPTERS CAPITAL MANAGEMENT... Bought 13.7 Thousand shares of Rosetta Genomics Ltd
CITIGROUP GLOBAL MARKETS INC. (B... Bought 4.3 Thousand shares of Rosetta Genomics Ltd